Ascend Wellness Holdings (AAWH) Non-Current Debt (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Non-Current Debt came in at $292.3 million in Q1 2026, up 16.18% year-on-year from $251.6 million in Q1 2025, and down 8.52% quarter-over-quarter from $319.5 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Non-Current Debt (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Non-Current Debt history runs 7 years deep, the most recent figure standing at $292.3 million for Q1 2026.

  • On a quarterly basis, Non-Current Debt rose 16.18% year-over-year to $292.3 million in Q1 2026; TTM through Mar 2026 was $292.3 million, a 16.18% increase from a year earlier, with the FY2025 full-year figure at $319.5 million, up 3.73% from the prior year.
  • Non-Current Debt retreated to $292.3 million in Q1 2026 per AAWH's latest filing, from $319.5 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $343.7 million in Q3 2025 and bottomed at $222.6 million in Q1 2022.
  • The 5-year median for Non-Current Debt is $297.6 million (2023), against an average of $293.3 million.
  • Across the five-year window, Non-Current Debt surged 169.31% in 2022 and fell 23.12% in 2024, its largest moves.
  • Year by year, Non-Current Debt stood at $319.3 million in 2022, then decreased by 6.81% to $297.6 million in 2023, then rose by 3.51% to $308.0 million in 2024, then gained by 3.73% to $319.5 million in 2025, then dropped by 8.52% to $292.3 million in 2026.
  • Per Business Quant, the three latest AAWH Non-Current Debt figures stand at $292.3 million (Q1 2026), $319.5 million (Q4 2025), and $343.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 10.34 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 14.02 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 27.86 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 12.41 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.74 Bn
10 Ascend Wellness Holdings 83.00 Mn 22.91 Mn 44.88 Mn 292.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 292.31 Mn
Dec 31, 2025 319.52 Mn
Sep 30, 2025 343.75 Mn
Jun 30, 2025 323.44 Mn
Mar 31, 2025 251.61 Mn
Dec 31, 2024 308.02 Mn
Sep 30, 2024 232.16 Mn
Jun 30, 2024 289.53 Mn
Mar 31, 2024 288.70 Mn
Dec 31, 2023 297.57 Mn
Sep 30, 2023 301.99 Mn
Jun 30, 2023 300.78 Mn
Mar 31, 2023 321.42 Mn
Dec 31, 2022 319.30 Mn
Sep 30, 2022 290.97 Mn
Jun 30, 2022 282.05 Mn
Mar 31, 2022 222.59 Mn
Dec 31, 2021 230.85 Mn
Sep 30, 2021 230.50 Mn
Jun 30, 2021 104.73 Mn